Cryopreservation of hematopoietic stem cells

American Journal of Hematology

Volumn 82, Issue 6, 2007, Pages 463-472

  Berz, David ^a   McCormack, Elise M ^a   Winer, Eric S ^a   Colvin, Gerald A ^a   Quesenberry, Peter J ^a  

^a ROGER WILLIAMS MEDICAL CENTER   (United States)

Author keywords

Cryopreservative; Freezing methods; Marrow; Stem cell

Indexed keywords

ANIMAL CELL; BONE MARROW CELL; CELL POPULATION; CORD BLOOD STEM CELL TRANSPLANTATION; CRYOPRESERVATION; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; STANDARD; TECHNIQUE;

COLONY-FORMING UNITS ASSAY; CRYOPRESERVATION; FREEZING; HEMATOPOIETIC STEM CELLS; HUMANS; INFECTION CONTROL;

EID: 34249789285     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.20707     Document Type: Review

References (107)

1. Stockschlaeder M, Hassan HT, Krog C. Long term follow up of leukemic patients after related cryopreserved bone marrow transplantation. Br J Haematol 1997;96:382-386.
2. Valeri CR, Pivacek LE. Effects of the temperature, the duration of frozen storage, and the freezing container on in vitro measurements in human peripheral blood mononuclear cells. Transfusion 1996;36:303-308.
3. Sanz MA. Cord-blood transplantation in patients with leukemia - a real alternative for adults. N Engl J Med 2004;351:2328-2330.
4. Rowley SD, Bensinger WI, Gooley TA, Buckner CD. Effect of cell concentration on bone marrow and peripheral blood stem cell cryopreservation. Blood 1994;83: 2731-2736.
5. Rebulla P. Cord blood banking 2002: 112,010 of 7,914,773 chances. Transfusion 2002;42:1246-1248.
6. Balint B, Ivanovic Z, Petakov M, et al. The cryopreservation protocol optimal for progenitor recovery is not optimal for preservation of marrow repopulating ability. Bone Marrow Transplant 1999;23:613-619.
7. Davis JM, Rowley SD, Braine HG, Piantadosi S, Santos GW. Clinical toxicity of cryopreserved bone marrow graft infusion. Blood 1990;75:781-786.
8. Hoyt R, Szer J, Grigg A. Neurological events associated with the infusion of cryopreserved bone marrow and/or peripheral blood progenitor cells. Bone Marrow Transplant 2000;25:1285-1287.
9. Cilloni D, Garau D, Regazzi E, Sammarelli G, et al. Primitive hematopoietic progenitors within mobilized blood are spared by uncontrolled rate freezing. Bone Marrow Transplant 1999;23:497-503.
10. Galmes A, Besalduch J, Bargay J, et al. Long-term storage at -80°C of hematopoietic progenitor cells with 5% dimethyl sulfoxide as the sole cryoprotectant. Transfusion 1999;39:70-73.
11. Aird W, Labopin M, Gorin NC, Antin JH. Long-term cryopreservation of human stem cells. Bone Marrow Transplant 1992;9:487-490.
12. Halle P, Tournilhac O, Knopinska-Posluszny W, et al. Uncontrolled-rate freezing and storage at -80°C, with only 3.5% DMSO in cryoprotective solution for 109 autologous peripheral blood progenitor cell transplantations. Transfusion 2001;41:667-673.
13. Katayama Y, Yano T, Bessho A, et al. The effects of a simplified method for cryopreservation and thawing procedures on peripheral blood stem cells. Bone Marrow Transplant 1997;19:283-287.
14. Perez-Oteyza J, Bornstein R, Corral M, et al. Controlled-rate versus uncontrolled-rate cryopreservation of peripheral blood progenitor cells: A prospective multicenter study. Group for cryobiology and biology of bone marrow transplantation (CBTNO), Spain. Haematologica 1998;83:1001-1005.
15. Matsumoto N, Yoshizawa H, Kagamu H, et al. Successful liquid storage of peripheral blood stem cells at subzero non-freezing temperature. Bone Marrow Transplant 2002;30:777-784.
16. Humpe A, Riggert J, Vehmeyer K, et al. Comparison of CD34+ cell numbers and colony growth before and after cryopreservation of peripheral blood progenitor and stem cell harvests: Influence of prior chemotherapy. Transfusion 1997;37:1050-1057.
17. Wang SY, Hsu ML, Huang MZ, et al. The activity in ex vivo expansion of cord blood myeloid progenitor cells before and after cryopreservation. Acta Haematol 2001;105:38-44.
18. Rubinstein P, Rosenfield RE, Adamson JW, Stevens CE. Stored placental blood for unrelated bone marrow reconstitution. Blood 1993;81:1679-1690.
19. Rubinstein P, Dobrila L, Rosenfield RE, et al. Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc Natl Acad Sci USA 1995;92:10119-10122.
20. Hechler G, Weide R, Heymanns J, Koppler H, Havemann K. Storage of noncryopreserved periphered blood stem cells for transplantation. Ann Hematol 1996;72:303-306.
21. Ruiz-Arguelles GJ, Ruiz-Arguelles A, Perez-Romano B, Marin-Lopez A, Larregina-Diez A, Apreza-Molina MG. Filgrastim-mobilized peripheral-blood stem cells can be stored at 4°C and used in autografts to rescue high-dose chemotherapy. Am J Hematol 1995;48:100-103.
22. Lewis JP, Passovoy M, Conti SA, McFate PA, Trobaugh FE, Jr. The effect of cooling regimens on the transplantation potential of marrow. Transfusion 1967;7:17-32.
23. Meryman HT, Williams RJ, Douglas MS. Freezing injury from "solution effects" and its prevention by natural or artificial cryoprotection. Cryobiology 1977;14:287-302.
24. Ketheesan N, Whiteman C, Malczewski AB, Hirst RG, La Brooy JT. Effect of cryopreservation on the immunogenicity of umbilical cord blood cells. Transfus Apher Sci 2004;30:47-54.
25. Paczkowska E. Freezing of umbilical blood cells in mechanical freezers (-80°C). Ann Acad Med Stetin 2002;48:117-133.
26. Walter Z, Szostek M, Weglarska D, et al. Methods for freezing, thawing and viability estimation of hemopoietic stem cells. Przegl Lek 1999;56:34-39.
27. Attarian H, Feng Z, Buckner CD, MacLeod B, Rowley SD. Long-term cryopreservation of bone marrow for autologous transplantation. Bone Marrow Transplant 1996;17:425-430.
28. Buchanan SS, Gross SA, Acker JP, Toner M, Carpenter JF, Pyatt DW. Cryopreservation of stem cells using trehalose: Evaluation of the method using a human hematopoietic cell line. Stem Cells Dev 2004;13:295-305.
29. Xiao M, Dooley DC. Assessment of cell viability and apoptosis in human umbilical cord blood following storage. J Hematother Stem Cell Res 2003;12:115-122.
30. Broxmeyer HE, Srour EF, Hangoc G, Cooper S, Anderson SA, Bodine DM. High-efficiency recovery of functional hematopoietic progenitor and stem cells from human cord blood cryopreserved for 15 years. Proc Natl Acad Sci USA 2003;100:645-650.
31. Yang H, Acker JP, Hannon J, Miszta-Lane H, Akabutu JJ, McGann LE. Damage and protection of UC blood cells during cryopreservation. Cytotherapy 2001;3:377-386.
32. Woods EJ, Liu J, Derrow CW, Smith FO, Williams DA, Criser JK. Osmometric and permeability characteristics of human placental/umbilical cord blood CD34+ cells and their application to cryopreservation. J Hematother Stem Cell Res 2000;9:161-173.
33. Zhang XB, Li K, Yau KH, et al. Trehalose ameliorates the cryopreservation of cord blood in a preclinical system and increases the recovery of CFUs, long-term culture-initiating cells, and non-obese diabetic-SCID repopulating cells. Transfusion 2003;43:265-272.
34. Vormoor J, Lapidot T, Pflumio F, et al. Immature human cord blood progenitors engraft and proliferate to high levels in severe combined immunodeficient mice. Blood 1994;83:2489-2497.
35. Vormoor J, Lapidot T, Pflumio F, et al. SCID mice as an in vivo model of human cord blood hematopoiesis. Blood Cells 1994;20:316-320; discussion 320-322.
36. Bock TA, Orlic D, Dunbar CE, Broxmeyer HE, Bodine DM. Improved engraftment of human hematopoietic cells in severe combined immunodeficient (SCID) mice carrying human cytokine transgenes. J Exp Med 1995;182:2037-2043.
37. Orazi A, Braun SE, Broxmeyer HE. Commentary: Immunohistochemistry represents a useful tool to study human cell engraftment in SCID mice transplantation models. Blood Cells 1994;20:323-330.
38. Kobylka P, Ivanyi P, Breur-Vriesendorp BS. Preservation of immunological and colony-forming capacities of long-term (15 years) cry-opreserved cord blood cells. Transplantation 1998;65: 1275-1278.
39. Mugishima H, Harada K, Chin M, et al. Effects of long-term cryopreservation on hematopoietic progenitor cells in umbilical cord blood. Bone Marrow Transplant 1999;23:395,396.
40. Kessinger A, Schmit-Pokorny K, Smith D, Armitage J. Cryopreservation and infusion of autologous peripheral blood stem cells. Bone Marrow Transplant 1990;5 (Suppl. 1):25-27.
41. Silberstein L, Jefferies L. Placental-blood banking - A new frontier in transfusion medicine. N Engl J Med 1996;335:199-201.
42. Kawano Y, Lee CL, Watanabe T, et al. Cryopreservation of mobilized blood stem cells at a higher cell concentration without the use of a programmed freezer. Ann Hematol 2004;83:50-54.
43. Cabezudo E, Dalmases C, Ruz M, et al. Leukapheresis components may be cryopreserved at high cell concentrations without additional loss of HPC function. Transfusion 2000;40:1223-1227.
44. Villalon L, Odriozola J, Ramos P, Ramos ML, Herrera P, de Oteyza JP. Cryopreserving with increased cellular concentrations of peripheral blood progenitor cells: Clinical results. Haematologica 2002;87:ELT06.
45. Gluckman E. Hematopoietic stem cell transplants using umbilical cord blood. N Engl J Med 2001;344:1860,1861.
46. Lovelock JE, Bishop MW. Prevention of freezing damage to living cells by dimethyl sulphoxide. Nature 1959;183:1394,1395.
47. Eberhardt R, Zwingers T, Hofmann R. DMSO in patients with active gonarthrosis. A double-blind placebo controlled phase III study. Fortschr Med 1995;113:446-450.
48. Albanell J, Baselga J. Systemic therapy emergencies. Semin Oncol 2000;27:347-361.
49. Branch DR, Calderwood S, Cecutti MA, Herst R, Solh H. Hematopoietic progenitor cells are resistant to dimethyl sulfoxide toxicity. Transfusion 1994;34:887-890.
50. Zambelli A, Poggi G, Da Prada G, et al. Clinical toxicity of cryopreserved circulating progenitor cells infusion. Anticancer Res 1998;18(6B):4705-4708.
51. Benekli M, Anderson B, Wentling D, Bernstein S, Czuczman M, McCarthy P. Severe respiratory depression after dimethylsulphoxide-containing autologous stem cell infusion in a patient with AL amyloidosis. Bone Marrow Transplantation 2000;25:1299-1301.
52. Miniero R, Vai S, Giacchino M, Giubellino C, Madon E. Severe respiratory depression after autologous bone marrow infusion. Haematologica 1992;77:98,99.
53. Hequet O, Dumontet C, El Jaafari-Corbin A, et al. Epileptic seizures after autologous peripheral blood progenitor infusion in a patient treated with high-dose chemotherapy for myeloma. Bone Marrow Transplant 2002;29:544.
54. Higman MA, Port JD, Beauchamp NJ, Jr., Chen AR. Reversible leukoencephalopathy associated with re-infusion of DMSO preserved stem cells. Bone Marrow Transplant 2000;26:797-800.
55. Ferrucci PF, Martinoni A, Cocorocchio E, et al. Evaluation of acute toxicities associated with autologous peripheral blood progenitor cell reinfusion in patients undergoing high-dose chemotherapy. Bone Marrow Transplant 2000;25:173-177.
56. Burger J, Gilmore MJ, Jackson B, Prentice HG. Acute haemoglobinaemia associated with the reinfusion of bone marrow buffy coat for autologous bone marrow transplantation. Bone Marrow Transplant 1991;7:322-324.
57. Zenhausern R, Tobler A, Leoncini L, Hess OM, Ferrari P. Fatal cardiac arrhythmia after infusion of dimethylsulfoxide cryopreserved hematopoietic stem cells in a patient with severe primary cardiac amyloidosis and end-stage renal failure. Ann Hematol 2000;79:523-526.
58. Windrum P, Morris TC, Drake MB, Niederwieser D, Ruutu T. Variation in dimenthyl sulfoxide use in stem cell transplantation: A survey of EBMT centres. Bone Marrow Transplant 2005;36:601-603.
59. Syme R, Bewick M, Stewart D, Porter K, Chadderton T, Gluck S. The role of depletion of dimethyl sulfoxide before autografting: On hematologic recovery, side effects, and toxicity. Biol Blood Marrow Transplant 2004;10:135-141.
60. Bakken AM, Bruserud O, Abrahamsen JF. No differences in colony formation of peripheral blood stem cells frozen with 5% or 10% dimethyl sulfoxide. J Hematother Stem Cell Res 2003;12:351-358.
61. Sasnoor LM, Kale VP, Limaye LS. Supplementation of conventional freezing medium with a combination of catalase and trehalose results in better protection of surface molecules and functionality of hematopoietic cells. J Hematother Stem Cell Res 2003;12:553-564.
62. Stroh C, Cassens U, Samraj AK, Sibrowski W, Schulze-Osthoff K, Los M. The role of caspases in cryoinjury: Caspase inhibition strongly improves the recovery of cryopreserved hematopoietic and other cells. FASEB J 2002;16:1651-1653.
63. Rollig C, Babatz J, Wagner I, et al. Thawing of cryopreserved mobilized peripheral blood-comparison between water bath and dry warming device. Cytotherapy 2002;4:551-555.
64. Moroff G, Seetharaman S, Kurtz JW, et al. Retention of cellular properties of PBPCs following liquid storage and cryopreservation. Transfusion 2004;44:245-252.
65. Calmels B, Houze P, Hengesse JC, Ducrot T, Malenfant C, Chabannon C. Preclinical evaluation of an automated closed fluid management device: Cytomate, for washing out DMSO from hematopoietic stem cell grafts after thawing. Bone Marrow Transplant 2003;31:823-828.
66. Shlebak AA, Marley SB, Roberts IA, Davidson RJ, Goldman JM, Gordon MY. Optimal timing for processing and cryopreservation of umbilical cord haematopoietic stem cells for clinical transplantation. Bone Marrow Transplant 1999;23:131-136.
67. Kurtzberg J, Laughlin M, Graham ML, et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med 1996;335:157-166.
68. Nagumura-Inoue T, Shioya M, Sugo M, et al. Wash-out of DMSO does not improve the speed of engraftment of cord blood transplantation: Follow-up of 46 adult patients with units shipped from a single cord blood bank. Transfusion 2003;43:1285-1295.
69. Beaujean F, Hartmann O, Kuentz M, Le Forestier C, Divine M, Duedari N. A simple, efficient washing procedure for cryopreserved human hematopoietic stem cells prior to reinfusion. Bone Marrow Transplant 1991;8:291-294.
70. Zingsem J, Strasser E, Weisbach V, et al. Cord blood processing with an automated and functionally closed system. Transfusion 2003;43:806-813.
71. Ayello J, Hesdorffer C, Reiss RF. A semi-automated technique for volume reduction of stem cell suspensions for auto transplantation. J Hematother 1995;4:545-549.
72. Rodriguez L, Azqueta C, Azzalin S, Garcia J, Querol S. Washing of cord blood grafts after thawing: High cell recovery using an automated and closed system. Vox Sang 2004;87:165-172.
73. Rodriguez L, Velasco B, Garcia J, Martin-Henao GA. Evaluation of an automated cell processing device to reduce the dimethyl sulfoxide from hematopoietic grafts after thawing. Transfusion 2005;45:1391-1397.
74. Mericka P, Schustr P, Vins M, et al. Containers for freezing and storage of bone marrow stem cells. Sb Ved Pr Lek Fak Karlovy University Hradci Kralove 1991;34(4):367-387.
75. Yang H, Acker JP, Cabuhat M, Letcher B, Larratt L, McGann LE. Association of post-thaw viable CD34+ cells and CFU-GM with time to hematopoietic engraftment. Bone Marrow Transplant 2005;35:881-887.
76. Hubel A, Carlquist D, Clay M, McCullough J. Liquid storage, shipment, and cryopreservation of cord blood. Transfusion 2004;44:518-525.
77. FDA. Current good tissue practice for manufacturers of human cellular tissue based products. Inspection and enforcement; Proposed rule 2001. Available at www.access.gpo.gov/su_docs/aces140.html.
78. Jestice HK, Farrington M, Hunt C, Matthews I, Scott MA, Foreman J, Marcus RE. Bacterial contamination of peripheral blood progenitor cells for transplantation. Transfus Med 1996;6:103-110.
79. Padley D, Koontz F, Trigg ME, Gingrich R, Strauss RG. Bacterial contamination rates following processing of bone marrow and peripheral blood progenitor cell preparations. Transfusion 1996;36:53-56.
80. Espinosa MT, Fox R, Creger RJ, Lazarus HM. Microbiologic contamination of peripheral blood progenitor cells collected for hematopoietic cell transplantation. Transfusion 1996;36:789-793.
81. Webb IJ, Coral FS, Andersen JW, et al. Sources and sequelae of bacterial contamination of hematopoietic stem cell components: Implications for the safety of hematotherapy and graft engineering. Transfusion 1996; 36:782-788.
82. Schwella N, Zimmermann R, Heuft HG, et al. Microbiologic contamination of peripheral blood stem cell autografts. Vox Sang 1994;67:32-35.
83. Prince HM, Page SR, Keating A, et al. Microbial contamination of harvested bone marrow and peripheral blood. Bone Marrow Transplant 1995;15:87-91.
84. Attarian H, Bensinger WI, Buckner CD, McDonald DL, Rowley SD. Microbial contamination of PBSC collections. Bone Marrow Transplant 1996;17:699-702.
85. Kipp F, Linnemann E, Fischer RJ, Sibrowski W, Cassens U. Cryopreservation reduces the concentration of detectable bacteria in contaminated peripheral blood progenitor cell products. Transfusion 2004;44:1098-1103.
86. Brecher ME, Means N, Jere CS, Heath D, Rothenberg S, Stutzman LC. Evaluation of an automated culture system for detecting bacterial contamination of platelets: An analysis with 15 contaminating organisms. Transfusion 2001;41:477-482.
87. Schafer TW, Everett J, Silver GH, Came PE. Biohazard: Virus-contaminated liquid nitrogen, Scientific Letter. Science 1976;191:25,26. No. 4222.
88. Tedder RS, Zuckerman MA, Goldstone AH, et al. Hepatitis B transmission from contaminated cryopreservation tank. Lancet 1995;346:137-140.
89. Hawkins AE, Zuckerman MA, Briggs M, et al. Hepatitis B nucleotide sequence analysis: Linking an outbreak of acute hepatitis B to contamination of a cryopreservation tank. J Virol Methods 1996;60:81-88.
90. Fountain D, Ralston M, Higgins N, et al. Liquid nitrogen freezers: A potential source of microbial contamination of hematopoietic stem cell components. Transfusion 1997;37:585-591.
91. Husebekk A, Skaug K, Kostad A, Dahl IM, Gutteberg T, Skogen B. Hepatitis B virus-infected peripheral blood progenitor cell harvests in liquid nitrogen freezer containing non-infectious products. Transfusion 2004;44:942,943.
92. Voak D, Cann R, Finney RD, et al. Guidelines for administration of blood products: Transfusion of infants and neonates. British Committee of Standards in Haematology Blood Transfusion Task Force. Transfus Med 1994;4:63-69.
93. Ware CB, Nelson AM, Blau CA. Controlled-rate freezing of human ES cells. Biotechniques 2005;38:879,880,882,883.
94. He J, Liu JH, Jiang K, Zhu FM, Yan LX. Assessment on effect of short-term cryopreservation of cord blood hematopoietic cells. Zhongguo Shi Yan Xue ye Xue za Zhi 2004;12:375-377.
95. Ure JM, Fiering S, Smith AG. A rapid and efficient method for freezing and recovering clones of embryonic stem cells. Trends Genet 1992;8:6.
96. Adams RM, Wang M, Crane AM, Brown B, Darlington GJ, Ledley FD. Effective cryopreservation and long-term storage of primary human hepatocytes with recovery of viability, differentiation, and replicative potential. Cell Transplant 1995;4:579-586.
97. Milosevic J, Storch A, Schwarz J. Cryopreservation does not affect proliferation and multipotency of murine neural precursor cells. Stem Cells 2005;23:681-688.
98. Dobrinksy JR. Cellular approach to cryopreservatiion of embryos. Theriogenology 1996;45:17-26.
99. Reubinoff BE, Pera MF, Vajta G, Trounson AO. Effective cryopreservation of human embryonic stem cells by the open pulled straw vitrification method. Hum Reprod 2001;16:2187-2194.
100. Fujioka T, Yasuchika K, Nakamura Y, Nakatsuji N, Suemori H. A simple and efficient cryopreservation method for primate embryonic stem cells. Int J Dev Biol 2004;48:1149-1154.
101. Zhou CQ, Mai QY, Li T, Zhuang GL. Cryopreservation of human embryonic stem cells by vitrification. Chin Med J (Engl) 2004;117:1050-1055.
102. Perseghin P, Epis R, Vigano M, Malacrida A, Pastorini A, Camerone G. Satisfactory recovery and viability of stem cells cryopreserved at high cell concentration. Transfus Sci 1997; 18: 399-403.
103. Liu K, Gao Z, Jiang Y, Dong W, et al. Collection, processing and cryopreservation of placental cord blood hematopoietic stem cells. Beijing Da Xue Bao 2003;35:119-122.
104. Barker JN, Wagner JE. Umbilical-cord blood transplantation for the treatment of cancer. Nat Rev Cancer 2003;3:526-532.
105. Donnenberg AD, Koch EK, Griffin DL, et al. Viability of cryopreserved BM progenitor cells stored for more than a decade. Cyto therapy 2002;4:157-163.
106. Nichols J, Zevnik B, Anastassiadis K, et al. Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 1998;95:379-391.
107. Yin AH, Miraglia S, Zanjani ED, et al. AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 1997;90:5002-5012.